In addition, glycyrrhizin, a commonly used HMGB1 inhibitor, significantly inhibited the expression of HMGB1 and thus c-MYC, thereby suppressing hepatocellular carcinoma [74]. Here, HMGB1 is linked to hepatocellular carcinoma.